Medy-Tox Inc (086900) - Total Liabilities

Latest as of September 2025: ₩119.26 Billion KRW ≈ $80.82 Million USD

Based on the latest financial reports, Medy-Tox Inc (086900) has total liabilities worth ₩119.26 Billion KRW (≈ $80.82 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Medy-Tox Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Medy-Tox Inc - Total Liabilities Trend (2013–2024)

This chart illustrates how Medy-Tox Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Medy-Tox Inc's balance sheet.

Medy-Tox Inc Competitors by Total Liabilities

The table below lists competitors of Medy-Tox Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Yem Chio Co Ltd TW:4306	Taiwan	NT$24.02 Billion
Flat Capital AB Series B ST:FLAT-B	Sweden	Skr538.59 Million
Taskus Inc NASDAQ:TASK	USA	$697.79 Million
Xuchang Ketop Testing Research Ins SHE:003008	China	CN¥45.68 Million
Ramco Industries Limited NSE:RAMCOIND	India	Rs-45.22 Billion
Asia Aviation Public Company Limited F:55AA	Germany	€61.59 Billion
Huizhong Instrumentation Co Ltd SHE:300371	China	CN¥107.14 Million
China Shengmu Organic Milk Limited F:7OM	Germany	€4.17 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Medy-Tox Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 086900 equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.79	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medy-Tox Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medy-Tox Inc (2013–2024)

The table below shows the annual total liabilities of Medy-Tox Inc from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩144.38 Billion ≈ $97.84 Million	+5.28%
2023-12-31	₩137.14 Billion ≈ $92.94 Million	-18.49%
2022-12-31	₩168.24 Billion ≈ $114.02 Million	-5.60%
2021-12-31	₩178.22 Billion ≈ $120.78 Million	-21.27%
2020-12-31	₩226.37 Billion ≈ $153.41 Million	+39.40%
2019-12-31	₩162.38 Billion ≈ $110.04 Million	+14.01%
2018-12-31	₩142.43 Billion ≈ $96.52 Million	-24.76%
2017-12-31	₩189.29 Billion ≈ $128.28 Million	+7.34%
2016-12-31	₩176.35 Billion ≈ $119.51 Million	+95.80%
2015-12-31	₩90.07 Billion ≈ $61.04 Million	+3.62%
2014-12-31	₩86.92 Billion ≈ $58.91 Million	+364.10%
2013-12-31	₩18.73 Billion ≈ $12.69 Million	--

About Medy-Tox Inc

KQ:086900 Korea Biotechnology

Market Cap

$300.49 Million

₩443.41 Billion KRW

Market Cap Rank

#14929 Global

#485 in Korea

Share Price

₩67400.00

Change (1 day)

+0.15%

52-Week Range

₩66900.00 - ₩138600.00

All Time High

₩671543.08